By Nigam Arora & Dr. Natasha Arora
Long time members of The Arora Report are long Walmart (WMT) from $19.25. The stock is trading at $74.77 as of this writing. This represents a gain of 288%.
Chart
Please click here for an annotated chart of WMT stock. Note the following:
- Technically WMT stock has broken out.
- The chart shows the support zone.
Earnings
Walmart earnings were released in the premarket this morning. Here are the key points:
- Walmart is not seeing consumer weakness. This data is contrary to other recent pieces of data. Smart money is always analyzing both sides. In contrast, the momo crowd pays attention only to the data that supports its position and ignores the rest.
- Weight loss drugs are contributing to healthy sales.
- High income earners have shifted to shopping at Walmart.
- Walmart reported EPS of $0.67 vs. $0.65 consensus for Q2.
- Walmart is projecting EPS of $0.51 – $0.52 vs. $0.54 consensus for Q3.
- Walmart is raising FY25 EPS to $2.35 – $2.43 vs. $2.23 – $2.37 prior.
Zones
For those who are following the Good Way, the Buy Now rating is *** (To see the locked content, please take a 30 day free trial).
For those following the Best Way, the buy zone is ***.
The recommended quantity is ***.
The very long term target is $96 – $103.
This is a very long term position.
What To Do Now
Those in the stock may consider continuing to hold. Those not in the stock may consider following the parameters given above.
Note: Signal(s) to enter, add, reduce, exit, hold or change.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
